SMTL ID : 8th3.1

Structure of AT118-H Nanobody Antagonist in Complex with the Angiotensin II Type I Receptor

Coordinates

PDB Format Compare

Method

ELECTRON MICROSCOPY

Oligo State

hetero-2-1-1-mer

Ligands

2 x Y01: CHOLESTEROL HEMISUCCINATE(Non-covalent)

Y01.1: 8 residues within 4Å: Chain A: L.194, L.203, N.204, L.207, F.245, C.284, I.285, W.288 7 PLIP interactions: 7 interactions with chain A Hydrophobic interactions: A:L.194, A:L.203, A:L.207, A:F.245, A:I.285, A:W.288, A:W.288 Y01.2: 8 residues within 4Å: Chain A: L.476, K.482, M.485, A.486, L.489, F.490, F.543, F.546 5 PLIP interactions: 5 interactions with chain A Hydrophobic interactions: A:L.489, A:L.489, A:F.490, A:F.543, A:F.546

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Skiba, M.A. et al., Antibodies expand the scope of angiotensin receptor pharmacology. Nat.Chem.Biol. (2024)

Release Date

2024-05-22

Peptides

AT118-H nanobody, Type-1 angiotensin II receptor, Soluble cytochrome b562 complex: AB
BAG2 Anti-BRIL Fab Heavy Chain: C
BAG2 Anti-BRIL Fab Light Chain: D

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

B
B

C
C

D
D

Membrane

We predict this structure to be a membrane protein.
Show / Hide

AT118-H nanobody, Type-1 angiotensin II receptor, Soluble cytochrome b562 complex

BAG2 Anti-BRIL Fab Heavy Chain

BAG2 Anti-BRIL Fab Light Chain

Related Entries With Identical Sequence